A Study of MM-111 and Paclitaxel With Trastuzumab in Patients HER2 Positive Carcinomas of the Distal Esophagus, Gastroesophageal (GE) Junction and Stomach
This study has been terminated.
(DSMB recommendation due to lack of efficacy. There were no safety signals.)
First Posted: January 24, 2013
Last Update Posted: June 22, 2017
Information provided by (Responsible Party):